Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 26;4(2):100719.
doi: 10.1016/j.crmeth.2024.100719.

Focused ultrasound-mediated delivery of viral neuronal tracers in marmosets

Bernie S Owusu-Yaw  1 , Nick Todd  2
Affiliations

Focused ultrasound-mediated delivery of viral neuronal tracers in marmosets

Bernie S Owusu-Yaw et al. Cell Rep Methods. .

Abstract

In this issue of Cell Reports Methods, Parks et al. present an approach to non-invasively deliver adeno-associated viruses in a marmoset model using focused ultrasound (FUS) for neuronal tracing. The optimization of this technique in this non-human primate model is highly valuable for future FUS-mediated drug delivery studies.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Figures

Figure 1
Figure 1
Illustration of FUS-mediated AAV delivery in a Marmoset model The marmosets were treated with FUS targeting the right area 8aD. BBB disruption was confirmed with MRI before the systemic delivery of AAV9 or AAV2. 4 to 6 weeks after treatment, the marmosets were euthanized, and the brains were harvested for immunofluorescence staining. Figure created using BioRender (https://biorender.com).
See this image and copyright information in PMC

References

    1. Pardridge W.M. Drug transport across the blood–brain barrier. J. Cereb. Blood Flow Metab. 2012;32:1959–1972. - PMC - PubMed
    1. Chaichana K.L., Pinheiro L., Brem H. Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas. Ther. Deliv. 2015;6:353–369. - PMC - PubMed
    1. Hordeaux J., Wang Q., Katz N., Buza E.L., Bell P., Wilson J.M. The neurotropic properties of AAV-PHP. B are limited to C57BL/6J mice. Mol. Ther. 2018;26:664–668. - PMC - PubMed
    1. McMahon D., O’Reilly M.A., Hynynen K. Therapeutic agent delivery across the blood–brain barrier using focused ultrasound. Annu. Rev. Biomed. Eng. 2021;23:89–113. - PMC - PubMed
    1. Kofoed R.H., Dibia C.L., Noseworthy K., Xhima K., Vacaresse N., Hynynen K., Aubert I. Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas. J. Control. Release. 2022;351:667–680. - PubMed

LinkOut - more resources